Does migraine protect your memory?

User rating: 4 / 5 after 7 vote(s)

Women with a lifetime history of migraine showed less of a performance decline over time on cognitive tests than women who didn’t have migraines. Researchers say medications for migraine, diet and behavior changes may play a role in helping women with migraine protect their memory. The findings are published in the April 24, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.


Full story »

All News summaries from Medicine & Health news
All News summaries for April 23, 2007

5 things you didn't know about... buying medication online

10 hours ago | User rating: not rated yet
Cynthia Reilly, director of the practice development division of the American Society of Health-Systems Pharmacists, offers advice for shopping online:

Scientists go chatting to hear kids' drug concerns

10 hours ago | User rating: not rated yet
(AP) -- It's nothing to LOL about. Students these days often have ready access to marijuana, alcohol and tobacco but they don't feel comfortable talking about the ramifications. So, some of the nation's government ...

End-of-life discussions with physicians may have benefits for patients and caregivers

10 hours ago | User rating: not rated yet
Terminally ill patients who had end-of-life discussions with physicians were not more likely to experience emotional distress, received less aggressive medical care in their final week of life and had a better quality of ...

Older renal cancer patients appear to benefit from sorafenib treatment

10 hours ago | User rating: not rated yet
Older and younger patients with renal cancer derive similar benefit from sorafenib therapy and tolerate the drug equally well, according to a study published online October 7 in the Journal of the National Cancer Institute.

Use of medication for enlarged prostate not associated with increased risk of hip fracture

10 hours ago | User rating: not rated yet
Use of a class of medications for treating an enlarged prostate, known as 5-α reductase inhibitors, are not associated with an increased hip fracture risk, according to a study in the October 8 issue of JAMA.